Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Sirona Biochem Corp
Bullboard Posts
User Avatar Image
(0)
•••
Comment by TechTargeton Oct 24, 2015 1:00am
80 Views
Post# 24223174

RE:RE:RE:Tech Traiter

RE:RE:RE:Tech Traiter
tickle1st wrote: So, that was not you unloading 2000 shares. ...


Not, if it was me, it would be a bit more. ;-)  LOL

I know you like non-producing mworthless iners but have you look at Healthcare stock recently?  Lots of xmas sales on! Limited time!  :-) LOL

Think it would make sense to sell SBM while it's languising here to buy into some of these 20% daily returns? Or do you think we might miss the next run if we pull out now?

Tell me ticke1st, you've been here forever!    Kinda makes you wonder doesn't it...hummm  :-) LOL

You seem to be negative on SBM. Look, let's make peace.  Let's both sell at the same time, go make some cahsh on the healths and slowly re-accumulate SBM after it;s tanked?   Deal?  :-)  LOL
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities